Kyle E. Evans
Impact in
-
- Computational Drug Discovery Methods
Papers in
-
- RNA regulation and disease 1
-
- Computational Drug Discovery Methods 2
- Co-authors
- Bradley T. Hyman (3 shared papers)Mark W. Albers (3 shared papers)Steve Rodriguez (2 shared papers)Sarah A. Boswell (2 shared papers)Peter K. Sorger (2 shared papers)Artem Sokolov (2 shared papers)Petar V. Todorov (1 shared paper)Nathan Johnson (1 shared paper)
- Journals
- Nature Communications (2 papers)Science Translational Medicine (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesGreeceIsrael
In The Last Decade
Kyle E. Evans
4 papers receiving 260 citations
Kyle E. Evans's Hit Papers
Peers
Comparison fields: 5 of 57
- Computational Theory and Mathematics 76
- Health Informatics 6
- Biological Psychiatry 8
- Neurology 22
- Pharmacology 35
Countries citing papers authored by Kyle E. Evans
This map shows the geographic impact of Kyle E. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle E. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle E. Evans more than expected).
Fields of papers citing papers by Kyle E. Evans
This network shows the impact of papers produced by Kyle E. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle E. Evans. The network helps show where Kyle E. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle E. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Machine learning identifies candidates for drug repurposing in Alzheimer’s disease Hit paper breakdown → | 2021 | 195 |
| 2 | 2022 | 35 | |
| 3 | 2021 | 30 | |
| 4 | 2025 | 1 |
About Kyle E. Evans
Kyle E. Evans is a scholar working on Molecular Biology, Computational Theory and Mathematics, Pharmacology, Genetics and Neurology, having authored 4 papers that have together received 261 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Computational Theory and Mathematics (76 citations), Health Informatics (6 citations), Biological Psychiatry (8 citations), Neurology (22 citations) and Pharmacology (35 citations). Kyle E. Evans has collaborated with scholars based in United States, Greece and Israel. Frequent co-authors include Bradley T. Hyman, Mark W. Albers, Steve Rodriguez, Sarah A. Boswell, Peter K. Sorger, Artem Sokolov, Petar V. Todorov, Nathan Johnson, Nienke Moret and Clemens B. Hug. Their work appears in journals such as Nature Communications, Science Translational Medicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.